Test Panel for Fast Diagnosis of Respiratory Diseases

(Madison, WI, USA), received the Frost and Sullivan Award for Potential Innovation of the Year. EraGen is a venture-backed biotechnology company focused on automating molecular diagnostics. It is establishing alliances within Wisconsin to address global health concerns and innovative diagnostic development throughout the state.

"Collaborative efforts have been going on for a few years now with Wisconsin-based infectious disease world leaders,” said Jim Prudent, Ph.D., CSO of EraGen Biosciences, "Our state is in many ways a Center of Excellence when it comes to viral influenza medical research and surveillance.”

The Multicode tests are being validated at the University of Wisconsin Hospital (Madison, USA) and other clinics. EraGen's ongoing collaborations within the state include the BloodCenter of Wisconsin (Milwaukee, WI, USA) and Promega Corporation (Madison, WI, USA).

The BloodCenter of Wisconsin is a multi-faceted organization focused on blood collection, diagnostic testing, treatment, and research. Promega provides innovative solutions and technical support to the life sciences industry, developing products for genomics, cellular analysis, molecular diagnostics, and human identification.



Related Links:
EraGen Bioscieces
Frost and Sullivan